RCKT News & Analysis

Rocket Pharmaceuticals (RCKT) CCO Sells $67,740 in Stock

The Chief Commercial Officer of Rocket Pharmaceuticals (RCKT) sold $67,740 worth of stock. This transaction adds to the existing insights regarding insider trading activities at the company. Such sales may indicate potential shifts in management confidence or company strategy. Investors typically monitor insider sales as they can influence market perceptions and stock performance.